Navigation Links
SFU materials and particle science attract government funding
Date:1/15/2013

The federal government through one of its research-funding agencies, the Canada Foundation for Innovation (CFI), is investing about $8.7 million in new funding in two major national research projects involving Simon Fraser University.

One is the Prometheus Project: BC's Multi-Institution Advanced Materials Science and Engineering Initiative, receiving $7.7 million. The other is the Upgrade to the ATLAS Tier-1 Data Analysis Centre, receiving $1 million.

Backgrounder #1 The Prometheus Project:

Led by Neil Branda, a Canada Research Chair in Materials Science and SFU chemistry professor, The Prometheus Project is destined to become a research hub for materials science and engineering innovation, and commercialization globally.

It brings together 10 principal researchers, including Branda, co-founder of SFU's 4D LABS, and 20 other scientists at SFU, University of British Columbia, the University of Victoria and the British Columbia Institute of Technology. They will create new materials science and engineering (MS&E) technology innovations, which will trigger and support sustained economic growth by creating, transforming and making obsolete entire industries.

Working with internationally recognized industrial, government, hospital and academic collaborators, scientists at the Prometheus partners' labs, including 4D LABS, a $40 million materials science research institute, will deliver innovations in three areas. The labs will:

  • Develop new solar-industry related materials and devices, including novel organic polymers, nanoparticles, and quantum dots, which will be integrated in low cost, high efficiency solar cell devices. The goal is to create a new generation of efficient solar cells that can compete in terms of cost with non-renewable technologies, surpassing older ones in terms of miniaturization and flexibility.

  • Develop miniaturized biosensors that can be used by individuals in c
    '/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Contemporary Product Solutions Released their Winter Dental Magazine by Evaluating Dental Products and Dental Materials From a "Total Team" Perspective
2. Aldrich Materials Science discovers liquid-free preparation of metal organic frameworks
3. A TECNALIA study reveals the loss of nanomaterials in surface treatments caused by water
4. Power generation technology based on piezoelectric nanocomposite materials developed by KAIST
5. No Added Cancer Risk From Hip Replacement Materials: Study
6. New electrically-conductive polymer nanoparticles can generate heat to kill colorectal cancer cells
7. Breakthrough nanoparticle halts multiple sclerosis
8. UGA researchers boost efficacy of drugs by using nanoparticles to target powerhouse of cells
9. Nanoparticles detect biochemistry of inflammation
10. Improved nanoparticles deliver drugs into brain
11. UCSB scientists examine effects of manufactured nanoparticles on soybean crops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Delhi, India (PRWEB) August 30, 2014 ... introduced low cost SEO service for small businesses. , ... or start-ups cannot afford costly search engine optimization service. ... budget of small businesses into account. , On ... said, “We have introduced this low cost SEO service ...
(Date:8/30/2014)... 2014 The establishment and creation ... been one of the main strategies of the ... positive impact around the world. , Architecturally stellar ... trained executives and trainers deliver L. Ron Hubbard's ... Vital statistics demonstrate that significant reduction in crime, ...
(Date:8/30/2014)... Acne is a common problem millions of American cope ... than a daily nuisance, for some, it can have a crippling ... even lead to dramatic mood swings and depression. , Those ... up their skin. In some cases, that can make the problem ... error, those on a quest for clearer skin can now view ...
(Date:8/30/2014)... VA (PRWEB) August 30, 2014 Seniors Guide, ... articles recently that focus on Alzheimer’s Disease, Dementia, and ... revealed to the public of being diagnosed with the Alzheimer’s, ... latest movie, “I’ll Be Me”. The movie, out on ... while focusing on his diagnosis of the disease – which ...
(Date:8/30/2014)... Manhattan Beach, Calif. (PRWEB) August 30, 2014 ... Carol Francis helps listeners understand how they unknowingly developed insomnia ... and have restful nights during. Tune in to the ... . The show airs live on August 30, and ... For more information on programming, go to DrCarolFrancisTalkRadio.com. ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
... , WEDNESDAY, Sept. 9 (HealthDay News) -- Young athletes ... cardiac death triggered by vigorous exercise, new Dutch research ... of death in young athletes, but no one knows ... reporting does not exist, the study authors noted. , ...
... Sept. 9 Reducing the risk of counterfeit drugs and contaminated medications ... the pharmaceutical and life sciences industries today, according to a new ... More than 50 percent of executives polled say their companies fail to ... their supply chain. , , (Logo: ...
... , LEWISTON, Maine and THOUSAND OAKS, Calif., Sept. 9 ... Challenge: A Journey for Hope, a cycling and 5K fundraising event scheduled ... Center for Cancer Hope & Healing at Central Maine Medical Center. ... Amgen,s Breakaway from Cancer ((R)) initiative, which aims to ...
... , FRANKLIN, Mass., Sept. 9 ... management company developing the needle-free Symphony(TM) tCGM System as ... and the Prelude(TM) SkinPrep System for transdermal drug delivery, ... at the Rodman & Renshaw 2009 Annual Global Investment ...
... , , , PORTLAND, Ore., Sept. ... chief executive officer of Regence BlueCross BlueShield: , , ... a pivotal conversation about health care reform. I applaud our nation,s ... "This August we saw an unfortunate polarization of our country. ...
... Calling all walkers, joggers, bikers and avid health & exercise buffs. Calling all couch potatoes, procrastinators, perpetual dieters and failed boot camp recruits! ... ... Thursday, September 10th, ... University Mall, ...
Cached Medicine News:Health News:Testing Young Athletes for Heart Defects May Save Lives 2Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 2Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 3Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 4Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 2Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 4Health News:Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference 2Health News:Health Insurer Regence Continues to Advocate for Meaningful Health Reform 2Health News:Grand Opening: An Exercise Program for People Who Just Love To Dance 2
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical ... Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it ... to address a potential issue with a clip ... the Axilla application of the SAM Junctional Tourniquet ...
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Primary knee system, symmetrical in design....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: